KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Precigen (PGEN) Equity Average (2016 - 2025)

Precigen (PGEN) has disclosed Equity Average for 13 consecutive years, with $2.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Equity Average fell 94.84% to $2.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.5 million, a 94.84% decrease, with the full-year FY2024 number at $78.5 million, down 35.85% from a year prior.
  • Equity Average was $2.5 million for Q3 2025 at Precigen, up from -$25.4 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $175.2 million in Q2 2023 to a low of -$25.4 million in Q2 2025.
  • A 5-year average of $96.1 million and a median of $107.8 million in 2024 define the central range for Equity Average.
  • Peak YoY movement for Equity Average: soared 170.56% in 2023, then plummeted 136.26% in 2025.
  • Precigen's Equity Average stood at $119.3 million in 2021, then increased by 12.66% to $134.4 million in 2022, then dropped by 0.97% to $133.1 million in 2023, then tumbled by 64.73% to $46.9 million in 2024, then crashed by 94.58% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for PGEN's Equity Average are $2.5 million (Q3 2025), -$25.4 million (Q2 2025), and $12.2 million (Q1 2025).